Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Cient. dent. (Ed. impr.) ; 18(3): 201-215, jun.-jul. 2021. ilus
Article in Spanish | IBECS | ID: ibc-217152

ABSTRACT

El tipo de alimentación que seguimos en nuestra vida cotidiana puede afectar a nuestra salud general y oral. De hecho, una dieta inadecuada se considera un factor de riesgo de las enfermedades crónicas no transmisibles entre las que se encuentra la periodontitis. Aunque los mecanismos patogénicos involucrados se deben determinar con exactitud, parece que la clave del proceso es la capacidad que tiene una alimentación poco saludable de condicionar la respuesta inflamatoria. Para aclarar mitos y realidades que rodean la relación entre la salud periodontal y la alimentación se realiza esta revisión narrativa de los conocimientos actuales. Para ello es necesario preguntarse cómo la respuesta inflamatoria puede ser modificada por la ingesta continuada de determinados alimentos, y cómo esa respuesta inflamatoria alterada puede participar en la patogénesis de la periodontitis. Las dietas ricas en hidratos de carbono refinados y/o en grasas saturadas y trans son capaces de inducir inflamación. Y esa respuesta inflamatoria hiperactivada participa de forma activa en la patogénesis de las periodontitis, contribuyendo a la destrucción de los tejidos periodontales. (AU)


The diet that we follow daily can affect our general and oral health. In fact, an inadequate diet is considered a risk factor for chronic non-communicable diseases, including periodontitis. Although the pathogenic mechanisms involved must be determined exactly, it seems that the key to the process is the ability of an unhealthy diet to condition the inflammatory response. To clarify myths and realities surrounding the relationship between periodontal health and diet, this narrative review of current knowledge is carried out. For this, it is necessary to ask ourselves how the inflammatory response can be modified by the continued intake of certain foods, and how this altered inflammatory response can participate in the pathogenesis of periodontitis. Diets rich in refined carbohydrates and / or saturated and trans fats are capable of inducing inflammation. And that hyperactivated inflammatory response actively participates in the pathogenesis of periodontitis, contributing to the destruction of periodontal tissues. (AU)


Subject(s)
Humans , 52503 , Periodontitis/diet therapy , Functional Food , Micronutrients , Antioxidants , Oxidative Stress
2.
Medicine (Baltimore) ; 100(25): e26369, 2021 Jun 25.
Article in English | MEDLINE | ID: mdl-34160409

ABSTRACT

BACKGROUND: Diseases of the oral cavity (OC) with an infectious trigger such as caries and periodontal disease are extremely common in the general population and can also have effects at the cardiovascular level. The oral salivary flow, with its buffering capacity, is able to regulate the pH of the OC and, therefore, significantly contribute to the ecological balance of the microenvironment in which the oral microbiome (OM) develops. On the other side, when the quality/quantity of salivary flow is altered it is supposed the disruption of this balance with the potential increase in oral pathogens and triggered diseases. Among the endogenous substances able to exert a significant effect on the salivary flow and its characteristics, carnosine (Car), a dipeptide originally isolated in skeletal muscle, represents, thanks to the known buffering properties, a promising principle. METHODS: We aimed this protocol to evaluate the quantitative/qualitative characteristics of the salivary flow in healthy volunteer subjects (n = 20) and in subjects suffering from common OC pathologies (n = 40), before and after 7 days of supplementation with SaliflussTM (Metis Healthcare srl, Milan, Italy), a Class I medical device on the market as 400 mg mucoadhesive oral tablets that has Car as the main ingredient. DISCUSSION: Combining the characteristics of saliva with the OM and comparing them with OC pathologies, we expect to clarify their reciprocal relationship and, using quantitative proteomics techniques, to help clarify the mechanism of action of Car.


Subject(s)
Carnosine/administration & dosage , Dental Caries/diet therapy , Gingivitis/diet therapy , Periodontitis/diet therapy , Saliva/chemistry , Administration, Buccal , Adolescent , Adult , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Dental Caries/complications , Dental Caries/prevention & control , Dietary Supplements , Gingivitis/microbiology , Gingivitis/prevention & control , Healthy Volunteers , Humans , Hydrogen-Ion Concentration , Male , Microbiota/physiology , Mouth Mucosa/microbiology , Periodontitis/microbiology , Periodontitis/prevention & control , Saliva/metabolism , Tablets , Young Adult
3.
Nutrients ; 12(9)2020 Aug 27.
Article in English | MEDLINE | ID: mdl-32867199

ABSTRACT

Periodontitis is a chronic multifactorial inflammatory disease that leads to the loss of supportive tissues around the teeth with gradual deterioration of masticatory function and esthetics, resulting eventually in the decrease of the life quality. Host immune response triggered by bacterial biofilm is responsible for the chronic periodontal inflammation and ongoing tissue loss. Omega-3 polyunsaturated fatty acids (PUFA) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have anti-inflammatory properties, thus may be used for the treatment of chronic inflammatory diseases. In this study, we aimed to evaluate the effect of dietary supplementation with omega-3 PUFA in the patients with stage III and IV periodontitis. Thirty otherwise healthy patients were treated with scaling and root planning (SRP). In the test group (n = 16), patients were additionally supplemented with 2.6 g of EPA and 1.8 g of DHA. In the control group (n = 14), patients received only SRP. Periodontal examination was performed at baseline and three months following initial therapy. Salivary samples were taken twice at baseline and at the end of the experiment. We found that there was a statistically significant reduction in the bleeding on probing (BOP) and improvement of clinical attachment loss (CAL) at three months in the test group compared to the control group. Moreover, a statistically significant higher percentage of closed pockets (probing depth ≤ 4 mm without BOP) was achieved in the test group vs. control group after three months of treatment. Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 PUFA at three months in comparison to the patients treated with SRP alone. Our findings demonstrate that dietary intervention with high-dose of omega-3 PUFA during non-surgical therapy may have potential benefits in the management of periodontitis.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Docosahexaenoic Acids/pharmacology , Eicosapentaenoic Acid/pharmacology , Periodontitis/diet therapy , Adult , Aged , Anti-Inflammatory Agents/administration & dosage , Dietary Supplements , Docosahexaenoic Acids/administration & dosage , Eicosapentaenoic Acid/administration & dosage , Fatty Acids, Omega-3 , Female , Humans , Male , Middle Aged , Treatment Outcome , Young Adult
4.
Rev. Asoc. Odontol. Argent ; 104(1): 42-47, mar. 2016.
Article in Spanish | LILACS | ID: lil-789834

ABSTRACT

Se realizó la revisión de los trabajos de investigación relacionados con la utilización de resolvinas y probióticos como complementos dietarios en la terapia periodontal, tanto en animales de experimentación como en humanos, describiendo el origen, la composición y los posibles mecanismos de acción. A partir de los trabajos revisados, se concluyó que las aludidas sustencias son, en la actualidad, un tema de investigación no traspolable a la clínica y que en el mediano plano, podrían potenciar las terapias actuales para patologías periodontales específicas.


Subject(s)
Humans , Periodontal Diseases/diet therapy , Dietary Supplements/classification , Dietary Supplements , Gingivitis/diet therapy , Gingivitis/prevention & control , Lipoxins/administration & dosage , Periodontitis/diet therapy , Periodontitis/prevention & control , Probiotics/administration & dosage
5.
J Periodontol ; 87(6): 725-34, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26846967

ABSTRACT

BACKGROUND: Anti-inflammatory and immunologic properties of cannabinoids have been reported in several tissues. Expression of cannabinoid receptor Type 2 was reported in osteoblasts and osteoclasts, suggesting a key role in bone metabolism. The aim of this study is to assess the effect of treatment with cannabinoid-2 receptor agonist HU-308 in the oral health of rats subjected to lipopolysaccharide (LPS)-induced periodontitis. METHODS: Twenty-four rats were distributed in four groups (six rats per group): 1) control rats; 2) sham rats; 3) rats submitted to experimental periodontitis (LPS); and 4) rats submitted to experimental periodontitis and treated with HU-308 (LPS+HU). In groups LPS and LPS+HU, periodontitis was induced by LPS (1 mg/mL) injected into the gingival tissue (GT) of maxillary and mandibular first molars and into the interdental space between the first and second molars, 3 days per week for 6 weeks. In group LPS+HU, HU-308 (500 ng/mL) was applied topically to the GT daily. RESULTS: Alveolar bone loss resulting from LPS-induced periodontitis was significantly attenuated with HU-308 treatment (LPS+HU), measured by macroscopic and histologic examination. Treatment also reduced gingival production of inflammatory mediators augmented in LPS-injected rats, such as: 1) inducible nitric oxide (iNOS) activity (LPS: 90.18 ± 36.51 pmol/minute/mg protein versus LPS+HU: 16.37 ± 4.73 pmol/minute/mg protein; P <0.05); 2) tumor necrosis factor alpha (LPS: 185.70 ± 25.63 pg/mg protein versus LPS+HU: 95.89 ± 17.47 pg/mg protein; P <0.05); and 3) prostaglandin E2 (PGE2) (LPS: 159.20 ± 38.70 pg/mg wet weight versus LPS+HU: 71.25 ± 17.75 pg/mg wet weight; P <0.05). Additionally, HU-308 treatment prevented the inhibitory effect of LPS-induced periodontitis on the salivary secretory response to pilocarpine. Moreover, iNOS activity and PGE2 content, which were increased by LPS-induced periodontitis in the submandibular gland, returned to control values after HU-308 treatment. CONCLUSION: This study demonstrates anti-inflammatory, osteoprotective, and prohomeostatic effects of HU-308 in oral tissues of rats with LPS-induced periodontitis.


Subject(s)
Cannabinoids/pharmacology , Periodontitis/diet therapy , Alveolar Bone Loss , Animals , Lipopolysaccharides , Rats , Receptors, Cannabinoid
6.
Georgian Med News ; (235): 63-9, 2014 Oct.
Article in Russian | MEDLINE | ID: mdl-25416220

ABSTRACT

The most common experimental model of periodontitis is a "ligature" model. However due to the complexity connected with performing on rats, modification of existing model is proposed, which differs by fixture of cotton ligature around the central incisor and not around the second molar. The purpose of research - a comparative evaluation of "peroxide" and modified by us, "ligature" models of periodontitis in rats. 2 series of experiments on 36 white Wistar rats were conducted. The animals were divided into two groups: intact rats (control) and rats with a "peroxide" model of periodontitis, which was reproduced by the addition to the diet of rats overoxidized sunflower oil (5% by weight of the feed), daily, for 45 days. "Ligature" model in rats was reproduced by applying a cotton ligature on the central incisor of the upper jaw for 14 days. Elastase activity, malondialdehyde content and catalase activity in the gums and in the blood serum was measured by biochemical methods. The degree of atrophy of the alveolar bone of the mandible was determined by morphometric method. It is found that in both models of periodontitis in rats, changes in the periodontal tissues and in the organism as a whole, is common for periodontal disease in humans. Clinically apparent inflammation of the periodontal tissues is observed, metabolic disorders in the gums, change of biochemical parameters in serum and progressive decline in the alveolar bone are determined. A comparative analysis of the two models showed that the modified "ligature" model of periodontitis in rats has several advantages over the "peroxide" model: shorter term of modeling, more pronounced clinical inflammation of periodontal tissues and faster resorption of alveolar bone.


Subject(s)
Lipids/administration & dosage , Periodontitis/diet therapy , Plant Oils/administration & dosage , Animals , Catalase/metabolism , Humans , Ligation/adverse effects , Lipid Peroxidation , Lipids/chemistry , Malondialdehyde/metabolism , Pancreatic Elastase/blood , Periodontal Pocket/metabolism , Periodontal Pocket/pathology , Periodontitis/blood , Periodontitis/physiopathology , Plant Oils/chemistry , Rats , Sunflower Oil
7.
Georgian Med News ; (235): 69-73, 2014 Oct.
Article in Russian | MEDLINE | ID: mdl-25416221

ABSTRACT

Biochemical changes that are taking place in patients with periodontitis 1 and 2 the quality of the individuals place in a laqtatdegidrogenazis, alkaline phosphatase activity increase and reduced activity amilazais. Therefore we can conclude that, there is an increase in superoxide substances, which causes an increase in the oral cavity patobakteriebis and quality of periodontitis. The grape seed and coriander oil is of vegetable origin and antioxidant drugs. Their action causes a statistically significant increase in the amilazis, alkaline phosphatase and laqtatdegidrogenazis reduction, while the latter leads pH - rate of return to oral fluid. It should be noted that the positive effect of coriander oil, but less effective.


Subject(s)
Grape Seed Extract/administration & dosage , Periodontitis/diet therapy , Plant Oils/administration & dosage , Alkaline Phosphatase/metabolism , Amylases/metabolism , Antioxidants/metabolism , Coriandrum/chemistry , Grape Seed Extract/chemistry , Humans , Malondialdehyde/metabolism , Periodontitis/metabolism , Periodontitis/physiopathology , Plant Oils/chemistry
8.
Oral Dis ; 18(1): 16-31, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21749581

ABSTRACT

A reduction in calorie intake [caloric restriction (CR)] appears to consistently decrease the biological rate of aging in a variety of organisms as well as protect against age-associated diseases including chronic inflammatory disorders such as cardiovascular disease and diabetes. Although the mechanisms behind this observation are not fully understood, identification of the main metabolic pathways affected by CR has generated interest in finding molecular targets that could be modulated by CR mimetics. This review describes the general concepts of CR and CR mimetics as well as discusses evidence related to their effects on inflammation and chronic inflammatory disorders. Additionally, emerging evidence related to the effects of CR on periodontal disease in non-human primates is presented. While the implementation of this type of dietary intervention appears to be challenging in our modern society where obesity is a major public health problem, CR mimetics could offer a promising alternative to control and perhaps prevent several chronic inflammatory disorders including periodontal disease.


Subject(s)
Caloric Restriction , Inflammation Mediators/antagonists & inhibitors , Inflammation/diet therapy , Adaptive Immunity , Animals , Biomimetics , Cardiovascular Diseases/diet therapy , Chronic Disease , Diabetes Mellitus/diet therapy , Humans , Immunity, Innate , Insulin-Like Growth Factor I/antagonists & inhibitors , Metformin/pharmacology , Periodontitis/diet therapy , Resveratrol , Signal Transduction/drug effects , Sirolimus/pharmacology , Sirtuins/drug effects , Stilbenes/pharmacology , TOR Serine-Threonine Kinases/antagonists & inhibitors
9.
J Med Life ; 4(4): 387-94, 2011 Nov 14.
Article in English | MEDLINE | ID: mdl-22514571

ABSTRACT

Periodontitis is one of the most common chronic inflammatory diseases. The etiology is clearly bacterial and a number of putative bacterial pathogens have been associated with the disease, including Aggregatibacter actinomycetemcomitans, Tannerella forsythus and Porphyromonas gingivalis. Comparatively, little attention has been paid to the identification of health-associated and potentially beneficial bacterial species that may reside in the gingival sulcus. Probiotic technology represents a breakthrough approach to maintaining oral health by using natural beneficial bacteria, commonly found in healthy mouths, to provide a natural defense against those bacteria which are thought to be harmful to teeth and gums. This article endeavors to introduce the concepts of probiotics in periodontics.


Subject(s)
Periodontitis/diet therapy , Periodontitis/prevention & control , Probiotics/therapeutic use , Aggregatibacter actinomycetemcomitans/pathogenicity , Humans , Periodontics/methods , Periodontitis/microbiology , Porphyromonas gingivalis/pathogenicity
10.
J Periodontal Res ; 42(1): 85-9, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17214644

ABSTRACT

BACKGROUND AND OBJECTIVE: It is conceivable that the active components extracted from milk whey protein (i.e. milk basic protein, MBP) stimulate bone formation and suppress bone resorption. Periodontitis is characterized by excessive alveolar bone resorption. We examined whether milk basic protein could recover alveolar bone loss in rat experimental periodontitis. MATERIAL AND METHODS: A nylon ligature was placed around the cervix of molars in 8-wk-old male Fischer rats for 20 d. Then, the ligature was removed and a powder diet containing 0.2 or 1.0% milk basic protein was provided daily for another 45-90 d. On days 45 and 90, the maxillae were extracted and analyzed using microcomputerized tomography (micro-CT), followed by histological analysis. RESULTS: Micro-CT images showed that alveolar bone resorption was severely induced around the molar by the 20-d ligature procedure. Treatment with high-dose milk basic protein (1.0%) clearly recovered ligature-induced alveolar bone resorption on days 45 and 90, whereas low-dose milk basic protein (0.2%) did not show such a clear effect. Histological examination clarified that the osteoid thickness of alveolar bone was dose dependently increased by milk basic protein treatment for 90 d. CONCLUSION: These findings suggest that a systemic administration of milk basic protein may be effective for the recovery of alveolar bone loss in periodontitis.


Subject(s)
Alveolar Bone Loss/diet therapy , Alveolar Process/drug effects , Dietary Proteins/therapeutic use , Milk Proteins/therapeutic use , Osteogenesis/drug effects , Periodontitis/diet therapy , Alveolar Bone Loss/diagnostic imaging , Alveolar Bone Loss/pathology , Alveolar Process/diagnostic imaging , Alveolar Process/pathology , Animals , Bone Matrix/diagnostic imaging , Bone Matrix/drug effects , Bone Matrix/pathology , Dietary Proteins/administration & dosage , Dose-Response Relationship, Drug , Image Processing, Computer-Assisted/methods , Male , Milk Proteins/administration & dosage , Periodontitis/diagnostic imaging , Periodontitis/pathology , Rats , Rats, Inbred F344 , Time Factors , Tomography, X-Ray Computed/methods , Whey Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...